Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on June 14, 2017, primarily to reaffirm its financial guidance for the full year 2017. The company informed investors that it expects net income to be greater than $10.37 per share, which includes an anticipated $1.23 per share in net unfavorable items. Excluding these items, the adjusted net income guidance remains strong, with the company expecting it to exceed $11.60 per share. This guidance is consistent with the information provided in the company's first quarter 2017 earnings release and does not incorporate any new adjustment items.
Key Highlights
- 1Elevance Health (then Anthem, Inc.) reaffirmed its full-year 2017 net income guidance.
- 2Projected net income for full year 2017 is expected to be greater than $10.37 per share.
- 3Anticipated net unfavorable items for 2017 are projected to be greater than $1.23 per share.
- 4Adjusted net income guidance for full year 2017 is expected to exceed $11.60 per share.
- 5The guidance reaffirmed does not include any adjustment items beyond those reported in the Q1 2017 earnings release.
- 6The information was shared in the context of upcoming investor meetings scheduled between June 14 and June 30, 2017.